Skip to content

MIND Programme for Cancer Patients

MIND Programme for Cancer Patients: A Group Intervention Programme Based on Third Wave Psychotherapies

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02943174
Enrollment
32
Registered
2016-10-24
Start date
2016-06-30
Completion date
2018-04-30
Last updated
2019-05-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer

Brief summary

This investigation aims to apply and test the acceptability of an acceptance, mindfulness and compassionate-based intervention structured for cancer patients. MIND programme for cancer thus comprises 8 weekly group sessions, lasting 1 and a half hour each, run in small groups at an Oncology Service at the Coimbra's University Hospital. For each week participants have assigned homework (e.g., mindfulness exercises). This programme mainly aims to increase participants' physical and psychosocial quality of life, and attenuate depressed mood and anxiety.

Detailed description

The sample will include diagnosed cancer patients recruited at an Oncology Service at the Coimbra's University Hospital. Patients will be approached by their doctor to assess their level of interest in the investigation. Patients who demonstrate interest will go through a Screening interview conducted by a licensed psychologist that aims explain the structure and arms of the investigation, to collect demographic data, and whether the patient meets the inclusion criteria for the study. Patients who meet the inclusion criteria and demonstrate interest in participating in the study, will sign an informed consent. All ethical requirements for research with humans are guaranteed. Afterwards, participants will be allocated in two groups (experimental and control group). Both groups will maintain the medical treatment as usual (TAU). Additionally, the experimental group will enroll in the MIND programme for cancer patients, also provided by a licensed psychologist. Both groups will concurrently complete a protocol of self-report measures and their medical data will be collected by the medical staff of the Hospital.

Interventions

BEHAVIORALMIND programme for cancer patients

Psychotherapeutic programme based on Acceptance, Mindfulness and Compassion for cancer patients Other: Cancer Treatment as Usual

OTHERTreatment as Usual (TAU)

Standard personalized treatment of cancer

Sponsors

University of Coimbra
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* diagnosis of breast cancer (stages I-III)

Exclusion criteria

* severe psychopathology * difficulty in completing self-report measures

Design outcomes

Primary

MeasureTime frameDescription
Changes in psychopathology (namely, depression and anxiety symptoms)From Baseline to follow-upMeasured by DASS-21
Changes in Quality of LifeFrom Baseline to follow-upMeasured by the World Health Organization Quality of Life questionnaire (WHOQOL-BREF)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026